8-Isoprostaglandin E2 Activates Ca2+-Dependent K+ Current Via Cyclic Amp Signaling Pathway in Murine Renal Artery

YD Zhang,E Pertens,LJ Janssen
DOI: https://doi.org/10.1016/j.ejphar.2005.08.009
IF: 5.195
2005-01-01
European Journal of Pharmacology
Abstract:The inhibitory pathway of 8-isoprostaglandin E2 was investigated in murine renal arterial smooth muscle. K+ current was augmented in a concentration-dependent fashion, with an average increase of 123±28% (n=6) following application of 10−5 M 8-isoPGE2. This augmentation was observed in the presence of 4-aminopyridine (4-AP, 10−3 M) but not that of charybdotoxin (ChTx, 10−7 M). Fluorimetric recordings showed marked concentration-dependent increase of cytosolic Ca2+ levels by 8-isoPGE2, while an enzyme-linked immunosorbent assay (ELISA)-based cyclic AMP assay showed increased cAMP levels by 10−7 M 8-isoPGE2 challenge. The isoprostane-induced augmentation was prevented by the ryanodine receptor blocker ruthenium red (10−5 M) or the adenylate cyclase blocker SQ 22536 (10−4 M). The protein kinase A (PKA) inhibitor H89 (10−5 M) inhibited resting K+ currents (78±5%, n=5) but did not prevent 8-isoPGE2 from augmenting the remaining K+ current. We conclude that 8-isoPGE2 enhances Ca2+-dependent K+ currents in murine renal artery through a cAMP-dependent pathway which may involve internally sequestered Ca2+.
What problem does this paper attempt to address?